Mycomax (Fluconazole)

Fluconazole, the active ingredient in Mycomax, is an azole antifungal presented as an oral tablet for systemic use. It is prescribed for the treatment of candidiasis, cryptococcal infections and other susceptible fungal infections in both adult and pediatric patients as determined by a healthcare professional.

GNH USA supplies Mycomax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant sourcing for global healthcare providers.

Fluconazole is used to treat fungal infections by targeting yeasts and molds in several clinical contexts.

Candidiasis: resolves mucosal and systemic Candida infections, reducing fungal burden and symptom severity. Cryptococcal meningitis: eradicates Cryptococcus neoformans from the central nervous system, improving survival outcomes. Other susceptible fungal infections: treats infections caused by susceptible yeasts and molds, such as blastomycosis and histoplasmosis, when indicated.

Fluconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset that may be transient. - Abdominal pain: discomfort or cramps often occurring after dosing. - Headache: transient cranial pain that usually resolves without intervention. - Rash: mild skin erythema or itching that may appear on trunk or limbs.

Serious or Rare Side Effects: - Hepatotoxicity: significant elevation of liver enzymes or clinically apparent liver injury requiring monitoring. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, demanding immediate medical attention. - Anaphylaxis: acute allergic response with respiratory distress, hypotension, or urticaria.

Before prescribing fluconazole, clinicians should consider several precautionary measures to ensure patient safety. - Liver function assessment: evaluate baseline hepatic enzymes and monitor during therapy. - Renal impairment adjustment: modify dose in patients with severe kidney dysfunction. - Drug interaction review: check concomitant medications that may affect fluconazole levels. - Hypersensitivity caution: avoid use in individuals with known allergy to azole antifungals. - Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. - Store at room temperature: keep tablets in original packaging, protect from moisture and heat.

Fluconazole interacts with several medicines; understanding the interaction level guides safe co‑administration.

Major Interactions (Avoid): - Warfarin: fluconazole can increase INR and bleeding risk. - QT‑prolonging agents (e.g., cisapride, terfenadine): combined use may cause serious cardiac arrhythmias. - Rifampin: induces metabolism, markedly reducing fluconazole plasma concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: fluconazole may reduce efficacy, consider additional contraceptive measures. - Phenytoin: fluconazole can lower phenytoin levels, requiring therapeutic monitoring.